Will the COVID vaccine kill the bond market?

Anthony Fensom | 22 Feb 2021

Page 1 of 1

The COVID-19 vaccine’s global rollout has coincided with rising bond yields, as investors anticipate higher inflation on the back of the expected post-pandemic recovery. Should fixed-income investors be worried?

Morningstar’s head of equities research, Peter Warnes, states that “low bond yields have provided an abundant supply of oxygen to risk asset valuations for several years … While investors have been rewarded by believing central banks and governments will support the economy no matter what, that support is unlikely to remain in place in perpetuity.”

Yet despite central banks’ massive monetary stimulus, long-term bond yields have recently hit their highest levels in nearly a year.

Australia’s benchmark 10-year bond yield has reached 1.4 per cent, up 43 basis points from year-end, while the US variant has also climbed by 37 basis points to 1.28 per cent, Warnes notes.

The yield curve continues to steepen, signalling accelerating economic growth and/or inflationary pressures,” Warnes said in the 18 February Your Money Weekly newsletter.

Evidence that inflation might be returning came from January’s US producer price index, which jumped by 1.3 per cent against expectations of a 0.4 per cent rise—“the largest monthly increase since the index underwent an overhaul in 2009.”

Westpac chief economist Bill Evans expects the US 10-year bond yield to reach 1.8 per cent by year-end, climbing to 2.4 per cent in 2022 on the back of accelerating global growth.

In Australia, inflation bounced back in the December quarter, with the consumer price index rising by 0.9 per cent, led by alcohol and tobacco and childcare. However, “underlying” inflation was just 1.3 per cent, well within the Reserve Bank of Australia’s (RBA’s) 2 to 3 per cent target band.

MORE ON THIS TOPIC: Australian Credit Monthly

RBA: No change until 2024

At its latest policy meeting on 2 February, the RBA maintained its 0.1 per cent target for its key cash rate and the three-year government bond yield, as well as adding another $100 billion in bond purchases.

The decision came amid “subdued” wage and price pressures, with both expected to remain below 2 per cent “over the next couple of years.”

The RBA said it would not increase interest rates until actual inflation is “sustainably within the 2 to 3 per cent target range. For this to occur, wages growth will have to be materially higher than it is currently … [requiring] significant gains in employment and a return to a tight labour market. The [RBA] does not expect these conditions to be met until 2024 at the earliest.”

Australia’s central bank has argued that its bond-buying has helped reduce the long-term government bond yield by about 30 basis points, as well as lowering the exchange rate. It also says the nation’s post-pandemic recovery remains dependent on the public health situation and on “significant fiscal and monetary support.”

Capital Economics expects the RBA to extend its quantitative easing (QE) program by another $100 billion, “perhaps in June,” with any further extension dependent partly on the actions of other central banks.

The London-based consultancy expects the RBA to cease further bond purchases at the end of August. It expects yields of 10-year developed market government bonds will not rise substantially until the end of 2022, with the US Federal Reserve unlikely to hike rates until 2024.

“In our view, major central banks will generally take a more cautious approach to tightening monetary policy than they did in the past. This underpins our forecast that the yields of 10-year government bonds in both developed and most emerging countries will generally remain below their pre-COVID-19 levels even as the global economy continues to recover over the next couple of years,” Capital Economics said in a 5 February report.

The latest minutes of the Fed’s policymaking committee stated it would continue accommodative policy until its employment and inflation targets (2 per cent over the longer run) had been met. Most economists do not expect any reduction in its QE program until 2022, according to a Bloomberg survey.

Stick to quality

With easy money seemingly set to continue for longer both in Australia and the US, how should bond investors react?

“The base case in the market currently is there will be an economic recovery in the second half of this year, as the [COVID-19] vaccine is rolled out. There will be some inflationary pressures and bond yields might start slowly creeping up, but I don’t think central banks will allow them to spike too fast, too soon and damage the recovery,” said John Likos, director, investment management at BondAdviser.

“All of those elements promote a risk-on environment, so investors will likely increase their equity allocations and go further down the capital structure in credit seeking higher-yielding opportunities,” he added.

However, Likos cautions against straying too far from quality issues in the search for yield.

“With benchmark rates still extremely low, we couldn’t caution more that you shouldn’t be chasing the higher risk issues. Make sure you’re invested with strong credits and reputable fund managers, not fly-by-night operators or highly leveraged issuers,” he said.

“While we don’t have any issue going down the capital structure in 2021, we’re doing it with the stronger issuers like the banks and telecommunications companies—investment-grade options. The message has never been more important to not chase yield beyond your risk tolerance this year.”

Prem Icon Morningstar's Global Best Ideas list is out now. Morningstar Premium subscribers can view the list here.

Prem Icon See also Morningstar Guide to International Investing

This report appeared on www.morningstar.com.au 2021 Morningstar Australasia Pty Limited

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Any general advice or 'class service' have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782 ("ASXO"). The article is current as at date of publication.